Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Scott Kinlay, Ph.D., M.B.,B.S.


This page shows the publications Scott Kinlay has written about Arteriosclerosis.
Connection Strength

  1. Effect of lipid-lowering therapy on vasomotion and endothelial function. Curr Cardiol Rep. 1999 Sep; 1(3):238-43.
    View in: PubMed
    Score: 0.138
  2. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol. 1997 Nov 06; 80(9A):11I-16I.
    View in: PubMed
    Score: 0.121
  3. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points. Curr Opin Lipidol. 1996 Dec; 7(6):389-97.
    View in: PubMed
    Score: 0.114
  4. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004 Jul 27; 110(4):386-91.
    View in: PubMed
    Score: 0.048
  5. Early statin therapy in acute coronary syndromes. Minerva Cardioangiol. 2003 Oct; 51(5):577-84.
    View in: PubMed
    Score: 0.046
  6. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10.
    View in: PubMed
    Score: 0.041
  7. What has intravascular ultrasound taught us about plaque biology? Curr Atheroscler Rep. 2001 May; 3(3):260-6.
    View in: PubMed
    Score: 0.039
  8. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis. Am J Cardiol. 2000 Oct 15; 86(8):890-2.
    View in: PubMed
    Score: 0.037
  9. Pathophysiology of atherosclerosis: development, regression, restenosis. Curr Atheroscler Rep. 2000 May; 2(3):251-8.
    View in: PubMed
    Score: 0.036
  10. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annu Rev Med. 2000; 51:149-67.
    View in: PubMed
    Score: 0.035
  11. Atherogenesis and ischemic heart disease. Am J Cardiol. 1997 Oct 30; 80(8B):3H-7H.
    View in: PubMed
    Score: 0.030
  12. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol. 1997 Mar 06; 79(5A):17-23.
    View in: PubMed
    Score: 0.029
  13. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension. 2003 Jul; 42(1):43-8.
    View in: PubMed
    Score: 0.011
  14. Lipid lowering improves endothelial functions. Int J Cardiol. 2000 Jun 30; 74 Suppl 1:S3-S10.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.